86 related articles for article (PubMed ID: 6671629)
1. [Antihypertensive action of elcatonin].
Takayanagi N; Tozuka T; Toda N
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):383-93. PubMed ID: 6671629
[TBL] [Abstract][Full Text] [Related]
2. Elcatonin-mediated contractile and relaxant responses in SHR femoral artery.
Fujimoto S; Fujimoto SK
Acta Pharmacol Sin; 2001 Jul; 22(7):595-602. PubMed ID: 11749822
[TBL] [Abstract][Full Text] [Related]
3. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
Hara Y; Nakahara H; Miyagishi A; Nakatani H
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of nuatigenin-3-O-β-chacotriose from Solanum sisymbriifolium Lam. (Solanaceae) (ñuatî pytâ) in experimentally hypertensive (ARH+DOCA) rats under chronic administration.
Ibarrola DA; Hellión-Ibarrola MC; Montalbetti Y; Heinichen O; Campuzano MA; Kennedy ML; Alvarenga N; Ferro EA; Dölz-Vargas JH; Momose Y
Phytomedicine; 2011 Jun; 18(8-9):634-40. PubMed ID: 21353509
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
6. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive effects of labetalol in three types of hypertensive models of rats (author's transl)].
Nakagawa Y; Takeda K; Sakurai H; Mitomi A; Imai S
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):435-45. PubMed ID: 7286847
[TBL] [Abstract][Full Text] [Related]
8. [Acute tolerance to the hypotensive effect of pindolol in spontaneously hypertensive rats (SHR)].
Matsunaga K; Ueda M
Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):259-66. PubMed ID: 6141128
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of [Asu1 . 7]-eel calcitonin on glucagon-induced glycogenolysis in perfused rat liver.
Mine T; Kimura S; Ogata E
Horm Metab Res; 1983 Mar; 15(3):139-43. PubMed ID: 6303930
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
Hefti F; Gerold M; Holck M
J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
[TBL] [Abstract][Full Text] [Related]
11. [The effect of parathormone on the reactivity of the renal blood flow to noradrenaline in normotensive and spontaneously hypertensive rats].
Brin VB; Tatrov AS; Iripkhanov BB
Fiziol Zh SSSR Im I M Sechenova; 1991 Apr; 77(4):59-64. PubMed ID: 1664361
[TBL] [Abstract][Full Text] [Related]
12. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
Januszewicz A; Loń S; Lapiński M; Styś A
J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
[TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
Hefti F; Clozel JP; Osterrieder W
Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
[TBL] [Abstract][Full Text] [Related]
15. [The effect of parathormone on the reactivity of the cardiovascular system to angiotensin-2 in normotensive and spontaneously hypertensive rats].
Brin VB; Tatrov AS
Fiziol Zh SSSR Im I M Sechenova; 1990 Mar; 76(3):345-50. PubMed ID: 2164967
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
[TBL] [Abstract][Full Text] [Related]
17. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]